ClinicalTrials.Veeva

Menu

Effect of Herbal Formulation on Thrombocytes Count

S

Shifa Ul Mulk Memorial Hospital

Status and phase

Enrolling
Phase 3

Conditions

Thrombocytopenia

Treatments

Drug: Karika Syrup

Study type

Interventional

Funder types

Other

Identifiers

NCT05563064
Shayan Fatima

Details and patient eligibility

About

Effect of Herbal Formulation Karika Syrup on Thrombocyte Count.

Full description

In this study, we will evaluate the effect of Herbal Formulation Karika (composed of Carica papaya leaf extract and Tinosporacordifolia) on Complete Blood Count, specifically on Platelet Count. Low Platelet Count is highly observant during multiple diseases namely dengue, malaria, typhoid, chikungunya, viral infections, and other Diseases.

The proposed study is a randomized, open, prospective, multicenter clinical trial. Extracts found in Karika syrup are beneficial in escalating platelet count, and also have anti-inflammatory and antipyretic activity. The therapeutic indication of Karika is proven through this clinical study in patients with low platelet count associated with dengue, typhoid, malaria, viral fever, and chikungunya fever.

Dengue is a tropical disease caused by the RNA virus which resides in mosquitoes. Symptoms include high-grade fever, visual disturbances, pain in the eyes and head, nausea, vomiting, musculoskeletal pain, stiffness of joints, mild to moderate and severe bleeding, and sometimes puerperal rash appearing on the skin due to a deficiency of thrombocytes.

The Chikungunya virus is spread by the bite of an infected mosquito. Typhoid is caused by Salmonella typhi a bacterium. Typhoid fever symptoms are seen widely in the human body that may observe from relatively minor cases of diarrhea with low-grade fever to high-grade fever and profound diarrhea with involvement of multiple systems.1

Enrollment

72 estimated patients

Sex

All

Ages

14 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Inclusion Criteria:

    1. Female and Male patients of age 14 to 60 years.
    2. Patient suffering from complaints of Weakness, Fatigue, Puerperal Rashes, Shortness of Breath, Low Hemoglobin, and History of Fever on & off, Epistaxis.18
    3. Patients from Karachi and Kapri Mori(Labors, Employed, Multigravida females, Housewives, Domestic helpers, Working women, School, College, and University Students).
    4. All socioeconomic classes are included in the study.
    5. Patients having a history of Covid-19, Viral fever, Typhoid, and other illnesses in which there has been a low platelet count.2

Exclusion criteria

  • Exclusion Criteria:

    1. Pregnant females are excluded.17
    2. Patients with co-morbidities like uncontrolled hypertension and liver disorder are excluded.4,5,6
    3. Patient having known drug reaction from any content of formulation is excluded.7
    4. Patients suffering from serious illnesses like encephalitis, coma, meningitis, or head injury that make them bedridden or hospitalized are excluded.4,6

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

72 participants in 1 patient group

Karika Syrup
Experimental group
Description:
Karika syrup has been used to treat thrombocytopenia
Treatment:
Drug: Karika Syrup

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems